Globe Newswire
APIA, Samoa, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Since the start of Q4, crypto markets have remained volatile and continued to weaken, with major assets retreating from their highs and market participants becoming more cautious. Against this backdrop, HTX Earn recently launched an APY Boost Promotion as part of the HTX Winter Campaign. The promotion offers APY boosts on 7-day Fixed products available on HTX Earn for seven assets, with APYs of up to 10%. It aims to... (continue reading...)
Beijing, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Elong Power Holding Limited (NASDAQ: ELPW, hereinafter referred to as "Elong Power" or the "Company") today announced that its wholly-owned subsidiary, Elong Power (Beijing) Co., Ltd. ("Elong Beijing"), has entered into a three-year energy storage equipment cooperation agreement with a total procurement value of no less than RMB2 billion (approximately US$300 million). The agreement takes effect on the date of signing, and... (continue reading...)
NEW YORK, Nov. 05, 2026 (GLOBE NEWSWIRE) -- CurePSP has awarded more than $1.4 million through its Biomarker Accelerator Program to three researchers working to find reliable biomarkers for progressive supranuclear palsy (PSP). The recipients are Dr. Günter Höglinger of Ludwig Maximilian University of Munich, Dr. Antoine Leuzy of ZRO Imaging and Dr. Maura Malpetti of the University of Cambridge.
A biomarker is a measurable sign of disease, found through tools such as... (continue reading...)
LONDON, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Geopolitical tensions are the top economic risk facing the life sciences industry, according to the latest report from Willis, a WTW business, (NASDAQ: WTW); Managing the new economic risks in life sciences. Based on insights from senior executives and risk professionals across North America, Europe and Asia, the research highlights growing concern that geopolitical rivalry, trade policy and government intervention are... (continue reading...)
Alphen aan den Rijn – November 5, 2026 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 499 of its own ordinary shares in the period from October 29, 2026, up to and including November 4, 2026, for €0.04 million and at an average share price of €85.06.
These repurchases are part of the share buyback program announced on February 25, 2026, under which we intend to... (continue reading...)
More Globe Newswire
View Older Stories-
69/2026・Trifork Group: Reporting of transactions made by persons discharging managerial responsibilities
-
Link Biologics completes IND-enabling preclinical programme for LB001, a first-in-class novel therapy for dry eye disease
-
BioPerfectus Introduces STAX-12A All-in-One Molecular Diagnostic System for Streamlined Sample-to-Result Workflows
-
Axis International files Memorial, maintaining its claim of USD 29 billion arbitration – as Guinea fails to make the first payment due to World Bank Tribunal
-
NOTICE TO DISREGARD -- Chery Group
-
ArrayPatch Completes Oversubscribed €3.2 Million Seed Financing to Advance Next-Generation Microneedle Therapeutics
-
X-SENSE XR0A-iR Smart Radon Detector Now Available on Lowes.com
-
Ethris Reports Positive Topline Phase 2a Data for Nasal mRNA Candidate ETH47 in Asthma Patients Challenged with Rhinovirus
-
The Ride Platform Evolves Its AI-Native Fleet Management Software Platform for the Operator Economy
-
Futu to Report Third Quarter 2026 Financial Results on November 19, 2026
-
Wayvia and Euronics Partner to Connect Brands, Independent Retailers and Shoppers Across 36 Markets
-
Einride and Lorenz Bring Autonomous Fleet to Production Facility in Germany
-
Alethio Therapeutics Raises $90 Million (£67 Million) in Oversubscribed Series A Financing to Advance a New Generation of Therapies for Myeloproliferative Neoplasms
-
Inbank Financial Calendar for 2027
-
Revenue for the nine months ended September 30, 2026
-
Capgemini selected to lead European Commission consortium for AI Safety and Cyber Risk Assessment of advanced AI models
-
Michelin: Disclosure of trading in own shares - November 5th, 2026
-
cBrain expects second-half revenue growth to exceed 20% and upgrades 2026 guidance
-
PRDots Launches in Dubai, Bringing Earned Media, Digital PR, AI Visibility and Link Building Services to Businesses Across the UAE
-
9M 2026: Novonesis delivered 7% organic sales growth, confirming full-year outlook
-
OSB GROUP PLC - Directorate change
-
Eesti Energia to begin preliminary consultations on collective redundancies
-
First Patient Dosed in Phase 1 Trial Evaluating Transgene’s and BioInvent's BT-001 in Patients with Rectal Cancer
-
Equiniti and Leading Banking and Investment Figures Convene to Answer: Can Share Plans Create Lifelong Investors?
-
First Patient Dosed in Phase 1 Trial Evaluating Transgene’s and BioInvent's BT-001 in Patients with Rectal Cancer
-
Eesti Energia Group Unaudited Results for Q3 2026
-
OSB GROUP PLC Announces Cash Tender Offers for its £300,000,000 Fixed Rate Resetting Notes due 7 September 2028 and £400,000,000 Fixed Rate Resetting Notes due 16 January 2030
-
Notice of Q3 2026 Results and Webcast Details
-
OSB GROUP PLC - Trading update for the nine months to 30 September 2026
-
NBPE Announces Transaction in Own Shares
-
T-Therapeutics announces oversubscribed $133 million Series B financing to achieve clinical proof-of-concept for first-in-class TCR bispecific therapies in cancer and autoimmune disease
-
Suominen Corporation’s Interim Report for January 1–September 30, 2026: Continued performance improvement in the third quarter
-
Major Shareholder Announcement
-
Interim report 9M 2026
-
Air France-KLM Q3 2026 Results
-
Interim Report Q3 2026
-
Upgrade of guidance for full year 2026
-
AL Sydbank delivers best quarterly performance and raises its expectations
-
AL Sydbank A/S to revise its expectations upwards as regards profit for 2026
-
New report: Small EU rule change could unlock 9.3 billion euros in investments for circular phosphorus production
-
Satisfactory Q3 result in special circumstances – capital adequacy continued to strengthen
-
ANI Pharmaceuticals Announces Offer to Acquire Egetis Therapeutics, Expanding the Scope and Scale of Its Rare Disease Business
-
Civinity AB continues its note programme: a new tranche of the note issue worth up to EUR 8,000,000, intended to finance the Group’s further expansion
-
Bouygues: Very strong nine-month 2026 Group results, Group full-year COPA now expected to increase slightly
-
Baltic Horizon Fund publishes interest rate applicable to the bonds for the next interest period
-
EfTEN United Property Fund unaudited financial results for 3rd quarter and 9 months of 2026
-
2026 9 months and III quarter consolidated unaudited interim report
-
Vivoryon Therapeutics N.V. Reports Q3 2026 Financial Results and Provides Business Update
-
FTI Consulting Appoints Aurélien Louis to Build on Transactions Capabilities in France
-
Siemens Healthineers to Rebrand In Vitro Diagnostics Business as Olyrian Diagnostics
